Mucocutaneous Lymph Node Syndrome
Information
- Disease name
- Mucocutaneous Lymph Node Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00000520 | Completed | Phase 2 | Prevention of Coronary Aneurysms in Kawasaki Syndrome | July 1985 | November 1989 |
| NCT00841789 | Completed | Phase 2 | A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease | March 2009 | August 30, 2018 |
| NCT03065244 | Completed | Phase 3 | KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) | February 17, 2017 | November 2, 2020 |
| NCT03880929 | Completed | Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017 | June 1, 2017 | March 1, 2019 | |
| NCT04509219 | Unknown status | Phase 1 | Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease | April 15, 2020 | August 31, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009080